Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
002788.SZ
HOLDGet insider-trade alertsLuyan Pharma Co.,Ltd. · Healthcare · China · $575M · Avg Vol: $26M/d
53
StockRankQ
48
V
73
M
25
P/E (TTM)
14.2x
ROE
8.3%
D/E
1.5x
Dividend %
3.3%
COMPANY DESCRIPTION
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 2.9B | 2.9B | 3.0B | 3.1B | 3.0% | 3.2B |
| EPS | 0.13 | 0.14 | 0.13 | 0.11 | -6.8% | 0.10 |
| Shares | 388.5M | 388.5M | 388.5M | 388.5M | 0.0% | 388.5M |
| Debt | 745.5M | 712.9M | 727.7M | 720.0M | -1.2% | 771.3M |
| Equity | 400.7M | 433.9M | 465.7M | 487.1M | 6.7% | — |
| Op CF | 34.2M | 192.8M | 85.1M | 101.4M | 43.7% | 76.6M |
| Inv CF | -48.5M | -78.7M | -54.5M | -35.9M | — | — |
| Fin CF | 27.2M | -104.4M | -48.4M | -64.8M | — | — |
Loading 1Y...
PRICE (1Y)-9.6%
SMA 50SMA 200
Close
$1.60
RSI (14)
45.3
52W High
$4.17
From 52W High
0.4%
SCORE BREAKDOWN
Quality
48
ROIC
14.5%84.3
ROE
8.3%66.2
GP/Assets
11.2%28.7
Op. Margin
2.7%50.2
FCF/Assets
3.4%60.7
Piotroski
549.0
Int. Cover
3.1x45.3
D/E Ratio
1.55x8.7
Current Ratio
1.11x14.1
Value
73
P/E (TTM)
14.2x75.1
EV/EBITDA
13.3x50.4
P/FCF
8.6x85.6
P/B
1.2x78.0
P/S
0.2x97.7
Div Yield
3.3%71.6
Momentum
25
52W High %
38%11.3
RS 6M
-46%21.4
SMA 50/200
0.93x47.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-5%35.6
FUNDAMENTALS
Market Cap
$575M
P/E (Forward)
—
Gross Margin
7.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002788.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 002788.SZ | Luyan Pharma Co.,Ltd.(you) | $575M | 53 | HOLD |
| 301017.SZ | ShuYu Civilian Pharmacy Corp., Ltd. | $783M | 41 | HOLD |
| 301408.SZ | Anhui Huaren Health Pharmaceutical Co., Ltd. | $835M | 72 | BUY |
| 9885.HK | YSB Inc. | $356M | 77 | BUY |
| 002727.SZ | Yixintang Pharmaceutical Group Co., Ltd. | $852M | 95 | STRONG BUY |
| 6086.HK | Fangzhou Inc. | $124M | 32 | SELL |
| 603883.SS | LBX Pharmacy Chain Joint Stock Company | $1.2B | 93 | STRONG BUY |
| 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $2.5B | 99 | STRONG BUY |
| 603939.SS | Yifeng Pharmacy Chain Co., Ltd. | $3.2B | 98 | STRONG BUY |
| 6618.HK | JD Health International Inc. | $13.0B | 84 | STRONG BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%